Results reported for Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis. Company plans to meet with the FDA to ...
A large French cohort study finds that pregnant women with systemic sclerosis face increased risks of preeclampsia, preterm ...
What if clinicians could place tiny electronic chips in the brain that electrically stimulate a precise target, through a ...
Target Loadings of 4% and 5% Rapamycin Achieved for Topical Lotion and Dermal Patch Delivery Technologies RespectivelyClinical Trial and ...
Target Loadings of 4% and 5% Rapamycin Achieved for Topical Lotion and Dermal Patch Delivery Technologies Respectively Clinical Trial and Stability Batch Manufacture to Commence in Q4 2025 Clinical Te ...
Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T ...
Microscopic wireless electronic devices hitch a ride on immune cells to reach the brain, offering therapeutic avenues for brain cancers and neurodegeneration.
PARK CITY, Utah — Movement Elevated, a new movement studio, is opening in lower Pinebrook, blending athletic training with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback